Source: Annual Congress 2013 –The role of hormones and cytokines in lung injury



Rating:

Share or cite this content

Citations should be made in the following way:
R. Ismael-Badarneh, J. Guetta, N. Abu-saleh, G. Klorin, G. Berger, Z. Abassi, Z. Azzam (Haifa, Israel). LATE-BREAKING ABSTRACT: Angiotensin II receptor 1 blocker (Losartan) restores the ability of the lung to clear edema in rats.. Eur Respir J 2013; 42: Suppl. 57, 3921

Member's Comments

No comment yet.

Related content which might interest you: C21, a nonpeptide angiotensin II type 2 receptor agonist attenuates lung fibrosis and associated cardiac dysfunction Source: International Congress 2015 – Pulmonary fibrosis: mechanisms of disease Year: 2015 LATE-BREAKING ABSTRACT: Activation of MTOR in pulmonary epithelium promotes LPS-induced acute lung injury Source: International Congress 2016 – Novel mechanisms and therapeutic targets in acute and chronic inflammatory disease Year: 2016 Effect of alveolar type II cells in acute lung injury model Source: International Congress 2015 – Novel insights into the pathobiology of acute lung injury Year: 2015 Angiotensin II receptor blockers, ACE inhibitors, lung function and percent emphysema; the MESA lung study Source: Annual Congress 2012 - Asthma and COPD: quality of life and comorbidities Year: 2012 Angiotensin II antagonism fails to ameliorate bleomycin-induced pulmonary fibrosis in mice Source: Eur Respir J 2005; 25: 708-714 Year: 2005 Preventive and therapeutic treatment with a7 nicotinic receptor agonist reduced lung inflammation and collagen deposition in mice with acute lung injury Source: International Congress 2014 – Experimental models in acute lung injury Year: 2014 Association between age-dependent changes in the pulmonary renin angiotensin system and severity of lung injury Source: International Congress 2015 – Novel insights into the pathobiology of acute lung injury Year: 2015 Abrogation of bleomycin induced inflammation and lung fibrosis by angiotensin AT1 receptor antagonist. Relevance of PGE-2 modulation Source: Eur Respir J 2005; 26: Suppl. 49, 82s Year: 2005 LATE-BREAKING ABSTRACT: Trasplantation of alveolar type II cells in experimental Acute Lung Injury Source: International Congress 2014 – Lung cell biology in injury and repair Year: 2014 Evaluation in administration of angiotensin II receptor antagonist Valsartan in the treatment of hypertension patients with chronic obstructive pulmonary disease. Source: International Congress 2019 – COPD treatment: cardiovascular, oxygen and vaccination studies Year: 2019 LATE-BREAKING ABSTRACT: Human mesenchymal stem cell exosomes attenuates sepsis-induced acute lung injury via inhibition of oxidative stress and the MAPK-NF-?B pathway Source: International Congress 2015 – Acute critical care: mechanical ventilation: how to limit the damage Year: 2015 LATE-BREAKING ABSTRACT: Influenza A virus infection reduces alveolar fluid clearance by activation of AMPK and subsequent reduction of Na,K-ATPase protein abundance Source: International Congress 2014 – Experimental models in acute lung injury Year: 2014 The effects of angiotensin II and related peptides on intracellular Ca2+ release in human lung fibroblasts Source: Annual Congress 2013 –The role of hormones and cytokines in lung injury Year: 2013 Down-regulation of RIP140 can prevent LPS-induced inflammation and acute lung injury in mice via PPARγ Source: International Congress 2015 – Novel insights into the pathobiology of acute lung injury Year: 2015 Dexamethasone inhibits secretory and cytosolic phospholipases A2 in alveolar macrophages in acute lung injury Source: Annual Congress 2013 –Macrophages, mononuclear cells and viral infection Year: 2013 Impact of blockers of AT1 receptors to angiotensin II on endothelium vasoregulating function in COPD patients Source: Eur Respir J 2006; 28: Suppl. 50, 739s Year: 2006 Effects of S-nitroso-N-acetyl-penicillamine (SNAP) on inflammation, apoptosis and iNOS activity in an experimental model of acute lung injury Source: International Congress 2015 – Acute critical care: novelties in critical care Year: 2015 LATE-BREAKING ABSTRACT: alpha-1 antitrypsin activates protein phosphatase 2A (PP2A) to counter lung inflammatory responses Source: International Congress 2014 – Lung cell biology in injury and repair Year: 2014 Late Breaking Abstract: Angiotensin II receptor blocker is associated with lower mortality in hospitalized patients with pneumonia Source: Annual Congress 2010 - From rare towards common lung diseases: diagnostic and monitoring challenges Year: 2010 Altered expression of claudin 5 isotype modulates tight junctions permeability in experimental LPS-induced acute lung injury in mice Source: Annual Congress 2013 –Novel mechanisms in lung injury Year: 2013